Pierre Laurent-Puig
机构: Université Paris Cité
每年引用次数
引用次数
引用: 74,212
H-指数: 117
I10-指数 : 390
出版物: 1,056
CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification.
C. Pilati , J. Taieb , R. Balogoun , L. Marisa
Annals of Oncology 28 ( 5) 1032 -1035
24
2017
Whole exome sequencing (WES) and RNA sequencing (RNA-seq) in routine clinical practice for colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) patients (pts)
G. Perkins , E. Fabre , V. Fallet , H. Blons
Annals of Oncology 27
2016
MiR-31-3p is a predictive biomarker of cetuximab response in FIRE3 clinical trial
P. Laurent-Puig , M.-L. Grisoni , V. Heinemann , K. Fontaine
Annals of Oncology 27
3
2016
Frequency of potentially actionable genetic alterations in EORTC SPECTAcolor
G. Folprecht , P. Beer , R. Salazar , A. Roth
Annals of Oncology 27
4
2016
Adjuvant FOLFOX+ cetuximab vs FOLFOX in full RAS and BRAF wild type stage III colon cancer patients: Results from the PETACC8 trial
J. Taieb , K. Le Malicot , R. Balogoum , J. Tabernero
Annals of Oncology 27 4610
2
2016
ERBB2 alterations a new prognostic biomarker in stage III colon cancer from a FOLFOX based adjuvant trial (PETACC8)
R. Balogoun , A. Cayre , K. Le Malicot , J. Tabernero
Annals of Oncology 27
13
2016
MErCuRIC1: A phase 1a study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor crizotinib in patients with advanced solid tumours
R. Wilson , M.R. Middleton , J. Houlden , S. Van Schaeybroeck
Annals of Oncology 27
1
2016
Prognostic value of circulating tumor DNA in advanced colorectal cancer patients: Quantification of hypermethylated or mutant sequences using picoliter droplet digital PC
A. Zaanan , F. Garlan , A. Didelot , G. Perkins
Annals of Oncology 27
2016
Pharmacogenetic analysis of toxicity after 5-fluorouracil (5FU) or 5FU/oxaliplatin therapy for metastatic colorectal cancer: Preliminary results in FFCD 2000–05 trial
M. Castaing , M. A. Loriot , M. Barrois , I. Miran
Journal of Clinical Oncology 25 2508 -2508
2007
Lipase/amylase ratio in pancreatitis: An etiologic index?
P. Laurent-Puig , A. Boutron , M.J. Briantais , K. Vahedi
Gastroenterology 103 ( 1) 353 -354
7
1992
GYNECOLOGIC SURVEILLANCE OF WOMEN AT RISK FOR HNPCC: RESULTS OF A PROSPECTIVE SERIES
F. Lecuru , S. Camatte , T. Lecomte , L. Lelievre
International Journal of Gynecologic Cancer 13 ( Suppl 1) 86.1 -86
2003
2167 Microsatellite status predicts BRAF V600E and KRAS exon 2 mutations prognostic value in stage III colon cancers (CC) patients treated with adjuvant FOLFOX +/- cetuximab. A post-hoc analysis of the PETACC8 trial
J. Taieb , A. Zaanan , K. Le Malicot , C. Julie
European Journal of Cancer 51
2015
208 Different prognostic impact of STK11 mutations in Non-Small-Cell Lung Cancer (NSCLC) illustrates the switch from a tumor suppressor to an oncogene
N. Pecuchet , P. Laurent-Puig , A. Mansuet-Luppo , A. Legras
European Journal of Cancer 51 S29 -S30
2015
420 Flash RAS study: RAS testing assessment in patients with metastatic colorectal cancer in 2014
M. Ducreux , A. Lievre , J.L. Merlin , P. Laurent-Puig
European Journal of Cancer 51
1
2015
468 Validity of next generation sequencing in routine care for non-small cell lung cancer diagnosis
A. Legras , N. Pecuchet , A. Tallet , A. Guyard
European Journal of Cancer 51
2015
Adjuvant Folfox4 with or without Cetuximab (CTX) in Patients (PTS) with Resected Stage III Colon Cancer (CC): Dfs and OS Results and Subgroup Analyses of the PETACC8 Intergroup Phase III Trial
J. Taieb , J. Tabernero , E. Mini , F. Subtil
Annals of Oncology 23
11
2012
Predictive Value of LKB1 in Patients with Resected Non Small Cell Lung Cancer
E. Fabre , N. Pécuchet , P. Laurent-Puig , K. Pallier
Annals of Oncology 23
2012
Review of the Current Status of Kras Mutation Testing in France in 2011: The Flash-Kras Study
M. Ducreux , A. Lièvre , P. Artru , M. Guiu
Annals of Oncology 23
2012
HSA-MIR31-3P Expression as a Predictor of Anti-Egfr Response in Wild-Type Kras Patients with Metastatic Colorectal Cancer
P. Laurent-Puig , G. Manceau , J. Bachet , B. Chibaudel
Annals of Oncology 23
2012
Small Bowel Adenocarcinoma Phenotype According to the Primary Localisation
T. Aparicio , M. Svrcek , A. Laforest , A. Zaanan
Annals of Oncology 23
1
2012